Effect of losartan, an AT1 selective angiotensin II receptor antagonist, on isoproterenol-induced cardiac ornithine decarboxylase activity

Res Commun Mol Pathol Pharmacol. 1995 Apr;88(1):21-30.

Abstract

Ornithine decarboxylase (ODC,EC 4.1.1.7), a rate-limiting enzyme in polyamine biosynthesis, is known to be induced by a beta-adrenoceptor agonist, isoproterenol (ISO). ODC activity and cardiac polyamine content are considered to be correlated with ISO-induced cardiac hypertrophy in rat hearts. To determine whether ISO-induced cardiac ODC activity is mediated through the renin-angiotensin system, especially at the AT1-receptor, we used a nonpeptide AT1 receptor antagonist, losartan, in this study. Losartan (10 mg/kg) suppressed both heart ODC and polyamine contents in ISO-treated rats. Although metoprolol (a selective beta-adrenoceptor antagonist) totally suppressed ODC activity, these results suggest that ISO-stimulated cardiac ODC activity may be regulated through beta 2-adrenoceptors coupled with AT1 receptors in rats.

MeSH terms

  • Angiotensin II / antagonists & inhibitors
  • Angiotensin II / metabolism*
  • Angiotensin Receptor Antagonists*
  • Animals
  • Biphenyl Compounds / pharmacology*
  • Heart / drug effects*
  • Imidazoles / pharmacology*
  • In Vitro Techniques
  • Isoproterenol / pharmacology*
  • Losartan
  • Metoprolol / pharmacology
  • Myocardium / enzymology*
  • Nephrectomy
  • Ornithine Decarboxylase / metabolism*
  • Ornithine Decarboxylase Inhibitors
  • Putrescine / metabolism
  • Rats
  • Rats, Wistar
  • Tetrazoles / pharmacology*

Substances

  • Angiotensin Receptor Antagonists
  • Biphenyl Compounds
  • Imidazoles
  • Ornithine Decarboxylase Inhibitors
  • Tetrazoles
  • Angiotensin II
  • Ornithine Decarboxylase
  • Metoprolol
  • Losartan
  • Isoproterenol
  • Putrescine